Agilent Life Sciences SSEL XT CRE V2, 96 auto
The Agilent SureSelect XT CRE V2, 96 reactions, automated (part number 5190-9493) is a targeted enrichment solution designed for use in next-generation sequencing (NGS) workflows. This kit enables automated preparation of DNA libraries for comprehensive cancer research, focusing on clinically relevant exons (CRE). The SureSelect XT CRE V2 kit is optimized for high-throughput environments, supporting up to 96 reactions per kit. It provides robust performance for capturing target regions with high specificity and uniformity, facilitating accurate variant detection in cancer genomics studies. The kit is compatible with automated liquid handling platforms, streamlining sample processing and reducing hands-on time.